Mild cognitive impairment and mild dementia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: In the elderly with normal cognition: 1. Aged between 55 and 75 years; 2. Normal activities of daily living, self-care or basic self-care; 3. Montreal Cognitive Assessment Scale (MoCA) of Fuzhou version is more than or equal to 25 points, and MOCA is more than or equal to 20 points if the length of education is less than or equal to 6 years; 4. Sign informed consent and volunteer to participate; 5. No obvious behavior and language barrier. MCI in the elderly: 1. According to Petersen's MCI diagnostic criteria; 2. Aged between 55 and 75 years; 3. The score of Montreal Cognitive Assessment (MoCA) of Fuzhou version is 19-24, and 14-19 if the length of education is less than or equal to 6 years; 4. Instrumental activities of daily living score (Lawton IADLs) > mean - 1.5 standard deviations; 5. Sign informed consent and volunteer to participate. Mild dementia: 1. Accord with the diagnostic criteria of AD; 2. Aged between 55 and 75 years; 3. Montreal Cognitive Assessment Scale (MoCA) of Fuzhou version is less than 19 points, and less than 14 points if the length of education is less than or equal to 6 years; 4. Instrumental activities of daily living score (Lawton IADLs) < mean - 1.5 standard deviations.
Exclusion criteria
Exclusion criteria: 1. The patients who had brain trauma, brain tumor, cerebral infarction, cerebral hemorrhage, intracranial infection, Parkinson's, epilepsy or other neurological diseases; 2. The patients who had depression, anxiety, schizophrenia or other mental illnesses; 3. The patient who took neurosuppressive drugs, antidepressant drugs, sedative drugs or antischizophreniadrugs in the past two weeks; 4. The patient who had history of alcohol or drug abuse (sleeping pills, painkillers, etc.); 5. The patient who wears glasses orthopedic difficult to see anything; 6. The patient who wears hearing aids also difficult to hear any sound; 7. The patient who are participating in other clinical trials that affect the evaluation of the results of this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neuropsychological assessment scale;Magnetic Resonance Image;Eye movement test; | — |
Countries
China
Contacts
Fujian University of Traditional Chinese Medicine